annual operating expenses:
$5.72B-$583.00M(-9.25%)Summary
- As of today (May 20, 2025), MRNA annual total operating expenses is $5.72 billion, with the most recent change of -$583.00 million (-9.25%) on December 31, 2024.
- During the last 3 years, MRNA annual operating expenses has risen by +$3.89 billion (+213.60%).
- MRNA annual operating expenses is now -9.25% below its all-time high of $6.30 billion, reached on December 31, 2023.
Performance
MRNA Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$1.07B-$396.00M(-27.07%)Summary
- As of today (May 20, 2025), MRNA quarterly total operating expenses is $1.07 billion, with the most recent change of -$396.00 million (-27.07%) on March 31, 2025.
- Over the past year, MRNA quarterly operating expenses has dropped by -$270.00 million (-20.19%).
- MRNA quarterly operating expenses is now -43.18% below its all-time high of $1.88 billion, reached on December 31, 2023.
Performance
MRNA quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
MRNA Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.3% | -20.2% |
| 3 y3 years | +213.6% | +53.3% |
| 5 y5 years | +862.5% | +690.4% |
MRNA Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -9.3% | +213.6% | -43.2% | +53.3% |
| 5 y | 5-year | -9.3% | +862.5% | -43.2% | +690.4% |
| alltime | all time | -9.3% | >+9999.0% | -43.2% | >+9999.0% |
MRNA Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $1.07B(-27.1%) |
| Dec 2024 | $5.72B(-9.3%) | $1.46B(+3.7%) |
| Sep 2024 | - | $1.41B(-3.9%) |
| Jun 2024 | - | $1.47B(+9.9%) |
| Mar 2024 | - | $1.34B(-28.8%) |
| Dec 2023 | $6.30B(+56.0%) | $1.88B(+20.5%) |
| Sep 2023 | - | $1.56B(+7.3%) |
| Jun 2023 | - | $1.45B(+2.8%) |
| Mar 2023 | - | $1.41B(-14.5%) |
| Dec 2022 | $4.04B(+121.6%) | $1.65B(+73.1%) |
| Sep 2022 | - | $954.00M(+29.3%) |
| Jun 2022 | - | $738.00M(+6.0%) |
| Mar 2022 | - | $696.00M(+18.6%) |
| Dec 2021 | $1.82B(+77.2%) | $587.00M(+6.9%) |
| Sep 2021 | - | $549.00M(+36.2%) |
| Jun 2021 | - | $403.00M(+41.9%) |
| Mar 2021 | - | $284.00M(-42.7%) |
| Dec 2020 | $1.03B(+73.2%) | $496.00M(+100.8%) |
| Sep 2020 | - | $247.00M(+63.6%) |
| Jun 2020 | - | $151.00M(+11.9%) |
| Mar 2020 | - | $135.00M(-3.8%) |
| Dec 2019 | $594.00M(+10.9%) | $140.40M(-2.6%) |
| Sep 2019 | - | $144.10M(-6.3%) |
| Jun 2019 | - | $153.74M(-1.3%) |
| Mar 2019 | - | $155.76M(-16.2%) |
| Dec 2018 | $535.78M(+20.0%) | $185.85M(+51.7%) |
| Sep 2018 | - | $122.48M(-0.3%) |
| Jun 2018 | - | $122.85M(+17.2%) |
| Mar 2018 | - | $104.86M(-19.5%) |
| Dec 2017 | $446.33M(+37.2%) | $130.24M(>+9900.0%) |
| Sep 2017 | - | $1.04M(+9.2%) |
| Jun 2017 | - | $948.90K(-1.9%) |
| Mar 2017 | - | $967.30K(+131.7%) |
| Dec 2016 | $325.31M(+6867.4%) | - |
| Dec 2016 | - | $417.40K(+327.2%) |
| Sep 2016 | - | $97.70K(-23.9%) |
| Jun 2016 | - | $128.40K(+12.4%) |
| Mar 2016 | - | $114.20K(-86.1%) |
| Dec 2015 | $4.67M(+16.1%) | $820.00K(-26.3%) |
| Sep 2015 | - | $1.11M(-21.8%) |
| Jun 2015 | - | $1.42M(+8.1%) |
| Mar 2015 | - | $1.31M(+11.5%) |
| Dec 2014 | $4.02M(+62.1%) | $1.18M(-26.6%) |
| Sep 2014 | - | $1.61M(+139.5%) |
| Jun 2014 | - | $671.00K(+19.2%) |
| Mar 2014 | - | $563.00K(-42.4%) |
| Dec 2013 | $2.48M(-76.2%) | $977.00K(+44.5%) |
| Sep 2013 | - | $676.00K(+34.9%) |
| Jun 2013 | - | $501.00K(+53.7%) |
| Mar 2013 | - | $326.00K(-87.5%) |
| Dec 2012 | $10.42M(-47.4%) | $2.61M(+93.0%) |
| Sep 2012 | - | $1.35M(-38.2%) |
| Jun 2012 | - | $2.19M(-48.9%) |
| Mar 2012 | - | $4.28M(+1.2%) |
| Dec 2011 | $19.81M(-30.4%) | $4.23M(-12.1%) |
| Sep 2011 | - | $4.81M(-12.9%) |
| Jun 2011 | - | $5.52M(+5.1%) |
| Mar 2011 | - | $5.25M(+10.2%) |
| Dec 2010 | $28.46M(+14.0%) | $4.76M(-58.4%) |
| Sep 2010 | - | $11.46M(+88.3%) |
| Jun 2010 | - | $6.08M(-1.2%) |
| Mar 2010 | - | $6.16M(+14.9%) |
| Dec 2009 | $24.97M | $5.36M(-21.2%) |
| Sep 2009 | - | $6.80M(+3.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2009 | - | $6.59M(+5.9%) |
| Mar 2009 | - | $6.22M(-49.1%) |
| Dec 2008 | $50.39M(-30.6%) | $12.24M(+21.1%) |
| Sep 2008 | - | $10.11M(-18.0%) |
| Jun 2008 | - | $12.32M(-21.7%) |
| Mar 2008 | - | $15.73M(-15.7%) |
| Dec 2007 | $72.57M(+26.3%) | $18.67M(-1.0%) |
| Sep 2007 | - | $18.86M(+5.5%) |
| Jun 2007 | - | $17.88M(+4.2%) |
| Mar 2007 | - | $17.16M(+8.1%) |
| Dec 2006 | $57.45M(+39.3%) | $15.87M(+13.9%) |
| Sep 2006 | - | $13.93M(+11.4%) |
| Jun 2006 | - | $12.50M(-17.5%) |
| Mar 2006 | - | $15.15M(+40.8%) |
| Dec 2005 | $41.23M(+37.1%) | $10.76M(+2.8%) |
| Sep 2005 | - | $10.46M(+1.7%) |
| Jun 2005 | - | $10.29M(+5.9%) |
| Mar 2005 | - | $9.72M(+33.0%) |
| Dec 2004 | $30.08M(+19.6%) | $7.30M(-3.9%) |
| Sep 2004 | - | $7.60M(+1.6%) |
| Jun 2004 | - | $7.49M(-2.6%) |
| Mar 2004 | - | $7.69M(+13.4%) |
| Dec 2003 | $25.15M(+16.3%) | $6.78M(+3.2%) |
| Sep 2003 | - | $6.57M(-3.3%) |
| Jun 2003 | - | $6.80M(+35.8%) |
| Mar 2003 | - | $5.00M(-25.6%) |
| Dec 2002 | $21.62M(+85.5%) | $6.72M(+23.0%) |
| Sep 2002 | - | $5.46M(+6.5%) |
| Jun 2002 | - | $5.13M(+19.1%) |
| Mar 2002 | - | $4.31M(+32.7%) |
| Dec 2001 | $11.65M(-21.5%) | $3.25M(+25.2%) |
| Sep 2001 | - | $2.59M(-7.3%) |
| Jun 2001 | - | $2.80M(-7.3%) |
| Mar 2001 | - | $3.02M(-40.7%) |
| Dec 2000 | $14.85M(+5.3%) | $5.08M(+65.1%) |
| Sep 2000 | - | $3.08M(-7.3%) |
| Jun 2000 | - | $3.32M(-1.3%) |
| Mar 2000 | - | $3.37M(-32.7%) |
| Dec 1999 | $14.10M(+38.2%) | $5.00M(+66.7%) |
| Sep 1999 | - | $3.00M(+7.1%) |
| Jun 1999 | - | $2.80M(-28.2%) |
| Mar 1999 | - | $3.90M(+5.4%) |
| Dec 1998 | $10.20M(+3.0%) | $3.70M(+54.2%) |
| Sep 1998 | - | $2.40M(-14.3%) |
| Jun 1998 | - | $2.80M(+33.3%) |
| Mar 1998 | - | $2.10M(-32.3%) |
| Dec 1997 | $9.90M(+607.1%) | $3.10M(+10.7%) |
| Sep 1997 | - | $2.80M(+16.7%) |
| Jun 1997 | - | $2.40M(+60.0%) |
| Mar 1997 | - | $1.50M(+36.4%) |
| Dec 1996 | $1.40M(-64.1%) | - |
| Sep 1996 | - | $1.10M(-8.3%) |
| Jun 1996 | $3.90M(+30.0%) | $1.20M(+33.3%) |
| Mar 1996 | - | $900.00K(0.0%) |
| Dec 1995 | - | $900.00K(0.0%) |
| Sep 1995 | - | $900.00K(-10.0%) |
| Jun 1995 | $3.00M(+233.3%) | $1.00M(+42.9%) |
| Mar 1995 | - | $700.00K(0.0%) |
| Dec 1994 | - | $700.00K(+16.7%) |
| Sep 1994 | - | $600.00K(+100.0%) |
| Jun 1994 | $900.00K | $300.00K(0.0%) |
| Mar 1994 | - | $300.00K(+200.0%) |
| Dec 1993 | - | $100.00K(-66.7%) |
| Sep 1993 | - | $300.00K |
FAQ
- What is Moderna annual total operating expenses?
- What is the all time high annual operating expenses for Moderna?
- What is Moderna annual operating expenses year-on-year change?
- What is Moderna quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Moderna?
- What is Moderna quarterly operating expenses year-on-year change?
What is Moderna annual total operating expenses?
The current annual operating expenses of MRNA is $5.72B
What is the all time high annual operating expenses for Moderna?
Moderna all-time high annual total operating expenses is $6.30B
What is Moderna annual operating expenses year-on-year change?
Over the past year, MRNA annual total operating expenses has changed by -$583.00M (-9.25%)
What is Moderna quarterly total operating expenses?
The current quarterly operating expenses of MRNA is $1.07B
What is the all time high quarterly operating expenses for Moderna?
Moderna all-time high quarterly total operating expenses is $1.88B
What is Moderna quarterly operating expenses year-on-year change?
Over the past year, MRNA quarterly total operating expenses has changed by -$270.00M (-20.19%)